2021, Number 05
<< Back Next >>
Ginecol Obstet Mex 2021; 89 (05)
Postpartum heart failure. The blame of oxytocin? A case report
Ruiz-Peña AC, Melero-Polo J, Laguna-Olmos M, Fernández-García C, Díaz-Rabasa B, de la Peña Dieste-Pérez AM
Language: Spanish
References: 10
Page: 409-414
PDF size: 176.46 Kb.
ABSTRACT
Background: Oxytocin is the most widely used drug in obstetrics and, among
other effects, is antidiuretic. High doses of it added to the volume overload typical of
pregnancy and to the fluid therapy administered during labor, can trigger heart failure
by several mechanisms.
Objective: To document a case of heart failure in the puerperium and review its etiology,
clinical, diagnosis, treatment and differential diagnosis and to alert to risk factors
centered on the indication of oxytocin and the administration of intrapartum serum.
Clinical case: Patient on the third day of puerperium who was readmitted for heart
failure secondary to several mechanisms: Water overload during labor induction,
pericardial effusion and high doses of oxytocin.
Conclusions: It is necessary to pay attention to fluid infusion during labor induction
because the combination of an antidiuretic drug, such as oxytocin, and a high serum
therapy load causes a water overload that can trigger cardiac complications.
REFERENCES
López-Ramírez CE, Arámbula-Almanza J, Camarena-Pulido EE. Oxitocina, la hormona que todos utilizan y que pocos conocen. Ginecol Obstet Mex 2014; 82: 472-82. http:// www.mauleduc.cl/material/4.-%20Oxitocina.pdf.
Mitre M, Minder J, Morina EX, Chao MV. Froemke RC. Oxytocin modulation of neural circuits. Curr Top Behav Neurosci 2017; 31-53. https://doi.org/10.1007/7854_2017_7.
Prasad MR, Funai E. Oxytocin use during active labor, too much of a good thing? Am J Obstet Gynecol 2012; 439-40. doi.10.1016/j.ajog.2012.09.005
Manning M, Misicka A, Olma A, Bankowski K, Stoev S. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol 2012; 24: 609-28. https://doi.org/10.1111/j.1365- 2826.2012.02303.x.
Kazimierz Wi. Design of oxytocin analogs. Methods Mol Biol 2019; 2001: 235-71. doi.10.1007/978-1-4939-9504-2_11.
Holleboom CAG, Eyck JV, Koenen SV, Kreuwel IAM. Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands. Arch Gynecol Obstet 2013; 287: 1111-17. https://doi.org/10.1007/s00404-012-2693-8.
MacDonald SK. Sex, receptors and attachment: a review of individual factors influencing response to oxytocin. Front Neurosci. 2013; 6: 1-8. https://doi.org/10.3389/ fnins.2012.00194.
Liccardi G, Bilò M, Mauro C, Salzillo A, Piccolo A, D’Amato M. Oxytocin: an unexpected risk for cardiologic and bronchoobstructive effects, and allergic reactions in susceptible delivering women. Multidisciplinary Respiratory Medicine, 2013; 8 (1): 67. https://doi.org/10.1186/2049-6958-8-67.
Ruchala PL, Metheny N, Essenpreis H, Borcherding K. Current Practice in Oxytocin Dilution and Fluid Administration for Induction of Labor. J Obstet Gynecol Neonatal Nurs 2002; 31 (5): 545-50. https://doi. org/10.1111/j.1552-6909.2002.tb00079.x.
Daly D, Minnie KCS, Blignaut A, Blix E, Vika Nilsen AB, Dencker A, et al. How much synthetic oxytocin is infused during labour? A review and analysis of regimens used in 12 countries. PLoS ONE 2020; 15 (7): e0227941. https:// doi.org/10.1371/journal.pone.0227941.